The risk for moderate to severe infection in later childhood was associated with overall infection burden in early life.

A licensed marriage and family therapist, Kingren works as an outpatient therapist, largely with adolescents, and has been a ...

Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach ...

A smaller version of the Vetlen Pouch, an antibiotic delivery system designed to administer antibiotics directly to wounds in ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ...

Korea: A recent retrospective cohort study published in the Journal of the American Academy of Dermatology explored the link ...

Panelists discuss how, when a patient progresses to second-line therapy, key considerations include prior treatment response, toxicity, patient comorbidities, and therapeutic goals. Lenvatinib shows ...

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.